R Squared’s Elevance Health ELV Stock Holding History

R Squared’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,158	Closed	-$374K	–	581
2025 Q3	$374K	Buy	+1,158	New	+$360K	0.16%	200
2025 Q1	–	Sell	-870	Closed	-$321K	–	650
2024 Q4	$321K	Buy	+870	New	+$364K	0.31%	58

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

R Squared's ELV Position: Q4 2025 in Review

R Squared sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,158 shares — an estimated $374K sold.

R Squared first reported a position in ELV in Q4 2024 and held it in 2 quarters. The position peaked at $374K in Q3 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

R Squared reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
R Squared sold 1,158 Elevance Health shares in Q4 2025, an estimated $374K.
R Squared first reported a position in Elevance Health in Q4 2024 and held it in 2 quarters.
R Squared's Elevance Health position peaked at $374K in Q3 2025.
1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on R Squared's 13F filing for Q4 2025, filed 30 Jan 2026.